These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 28338236

  • 1. hsa-mir-3199-2 and hsa-mir-1293 as Novel Prognostic Biomarkers of Papillary Renal Cell Carcinoma by COX Ratio Risk Regression Model Screening.
    Luo W, Wang L, Luo MH, Huang YZ, Yang H, Zhou Y, Jia HT, Wang XX.
    J Cell Biochem; 2017 Oct; 118(10):3488-3494. PubMed ID: 28338236
    [Abstract] [Full Text] [Related]

  • 2. Identification of Three Differentially Expressed miRNAs as Potential Biomarkers for Lung Adenocarcinoma Prognosis.
    Wang W, Liu B, Duan X, Feng X, Wang T, Wang P, Ding M, Zhang Q, Feng F, Wu Y, Yao W, Wang Q, Yang Y.
    Comb Chem High Throughput Screen; 2020 Oct; 23(2):148-156. PubMed ID: 31976830
    [Abstract] [Full Text] [Related]

  • 3. A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma.
    Zhan Y, Zhang R, Li C, Xu X, Zhu K, Yang Z, Zheng J, Guo Y.
    Cancer Med; 2021 Sep; 10(17):6128-6139. PubMed ID: 34288551
    [Abstract] [Full Text] [Related]

  • 4. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
    Zhang Z, Pan B, Lv S, Ji Z, Wu Q, Lang R, He Q, Zhao X.
    Cell Physiol Biochem; 2018 Sep; 49(2):678-695. PubMed ID: 30165365
    [Abstract] [Full Text] [Related]

  • 5. Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma.
    Luo Y, Chen L, Wang G, Xiao Y, Ju L, Wang X.
    J Cell Biochem; 2019 Aug; 120(8):13751-13764. PubMed ID: 30957284
    [Abstract] [Full Text] [Related]

  • 6. Integrated Analysis Revealed the MicroRNA-Based Prognostic Predicting Signature for Papillary Renal Cell Carcinoma.
    Guan Y, Wang B, Zhang T, Gao S, Cao Z, Zhang M, Liang C.
    DNA Cell Biol; 2021 Mar; 40(3):532-542. PubMed ID: 33625263
    [Abstract] [Full Text] [Related]

  • 7. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M, Kong X, Wang H, Huang G, Ye C, He Z.
    Oncotarget; 2017 Jan 31; 8(5):8775-8784. PubMed ID: 28060739
    [Abstract] [Full Text] [Related]

  • 8. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
    Xiong DD, Lv J, Wei KL, Feng ZB, Chen JT, Liu KC, Chen G, Luo DZ.
    Oncol Rep; 2017 Jun 31; 37(6):3297-3304. PubMed ID: 28440475
    [Abstract] [Full Text] [Related]

  • 9. Identification of a microRNA signature associated with survivability in cervical squamous cell carcinoma.
    Ma C, Zhang W, Wu Q, Liu Y, Wang C, Lao G, Yang L, Liu P.
    PLoS One; 2018 Jun 31; 13(3):e0193625. PubMed ID: 29513728
    [Abstract] [Full Text] [Related]

  • 10. Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma.
    Pang Y, Wang Y, Zhou X, Ni Z, Chen W, Liu Y, Du W.
    Int J Mol Sci; 2023 Jan 11; 24(2):. PubMed ID: 36674979
    [Abstract] [Full Text] [Related]

  • 11. Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
    Xiaoli Z, Yawei W, Lianna L, Haifeng L, Hui Z.
    Med Sci Monit; 2015 Dec 02; 21():3748-59. PubMed ID: 26628405
    [Abstract] [Full Text] [Related]

  • 12. A novel nine-microRNA-based model to improve prognosis prediction of renal cell carcinoma.
    Xu C, Zeng H, Fan J, Huang W, Yu X, Li S, Wang F, Long X.
    BMC Cancer; 2022 Mar 12; 22(1):264. PubMed ID: 35279104
    [Abstract] [Full Text] [Related]

  • 13. Identification of a nine-miRNA signature for the prognosis of Uveal Melanoma.
    Xin X, Zhang Y, Ling F, Wang L, Sheng X, Qin L, Zhao X.
    Exp Eye Res; 2019 Mar 12; 180():242-249. PubMed ID: 30615885
    [Abstract] [Full Text] [Related]

  • 14. [Bioinformatics on vascular invasion markers in hepatocellular carcinoma via Big-Data analysis].
    Chen Q, Qiu XQ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Apr 10; 38(4):522-527. PubMed ID: 28468075
    [Abstract] [Full Text] [Related]

  • 15. A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.
    Zhang J, Chong CC, Chen GG, Lai PB.
    PLoS One; 2015 Apr 10; 10(6):e0128628. PubMed ID: 26046780
    [Abstract] [Full Text] [Related]

  • 16. A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis.
    Yang G, Zhang Y, Yang J.
    Front Oncol; 2019 Apr 10; 9():1207. PubMed ID: 31799184
    [Abstract] [Full Text] [Related]

  • 17. Expression Profiles and Clinical Significance of MicroRNAs in Papillary Renal Cell Carcinoma: A STROBE-Compliant Observational Study.
    Ge YZ, Xu LW, Xu Z, Wu R, Xin H, Zhu M, Lu TZ, Geng LG, Liu H, Zhou CC, Yu P, Zhao YC, Hu ZK, Zhao Y, Zhou LH, Wu JP, Li WC, Zhu JG, Jia RP.
    Medicine (Baltimore); 2015 Apr 10; 94(16):e767. PubMed ID: 25906110
    [Abstract] [Full Text] [Related]

  • 18. Bioinformatics analyses of significant prognostic risk markers for thyroid papillary carcinoma.
    Min XS, Huang P, Liu X, Dong C, Jiang XL, Yuan ZT, Mao LF, Chang S.
    Tumour Biol; 2015 Sep 10; 36(10):7457-63. PubMed ID: 25908172
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, Jentzmik F, Miller K, Lein M, Kristiansen G, Jung K.
    Int J Cancer; 2010 Mar 01; 126(5):1166-76. PubMed ID: 19676045
    [Abstract] [Full Text] [Related]

  • 20. Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC.
    Liu C, Yu Z, Huang S, Zhao Q, Sun Z, Fletcher C, Jiang Y, Zhang D.
    EBioMedicine; 2019 Dec 01; 50():135-143. PubMed ID: 31780396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.